Microbiological Profiles of Patients with Periprosthetic Joint Infection of the Hip or Knee.
Frank Sebastian FröschenThomas Martin RandauAlexander FranzErnst MolitorGunnar Thorben Rembert HischebethPublished in: Diagnostics (Basel, Switzerland) (2022)
Periprosthetic joint infections (PJI) are one of the most devastating consequences after total joint arthroplasty. We sought to analyze the causative pathogens of patients with PJI to get better insights and improve treatment. We performed a retrospective study of all patients with PJI of the hip and knee with microbiological detection of a causative pathogen at a tertiary endoprothetic referral center between January 2016 and March 2021. A total of 432 cases with PJI (hip: n = 250; knee: n = 182) were included. The most common causative pathogen were coagulase-negative staphylococci ( n = 240; 44.2%), of which Staphylococcus epidermidis ( n = 144; 26.7%) was the most frequently detected, followed by S. aureus ( n = 77; 14.3%) and enterococci ( n = 49; 9%). Gram-negative pathogens and fungi could be detected in 21% ( n = 136) and 2.4% ( n = 13) of all cases. Overall, 60% of all coagulase-negative staphylococci were oxacillin-resistant, while none of these displayed to be vancomycin-resistant. In summary, the majority of pathogens in cases of PJI could be identified as coagulase-negative staphylococci. For empirical therapy vancomycin might provide the highest antimicrobial coverage in case of an unknown pathogen.
Keyphrases
- gram negative
- multidrug resistant
- antimicrobial resistance
- total hip arthroplasty
- total knee arthroplasty
- methicillin resistant staphylococcus aureus
- staphylococcus aureus
- candida albicans
- total hip
- biofilm formation
- knee osteoarthritis
- primary care
- anterior cruciate ligament
- pseudomonas aeruginosa
- cell therapy
- loop mediated isothermal amplification
- bone marrow
- smoking cessation
- replacement therapy